Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Medical Forum Monthly. 2009; 20 (1): 9-13
em Inglês | IMEMR | ID: emr-92075

RESUMO

This study was aimed to assess the anti-hyperglycemic effects of alphatocopherol. We assessed the hypothesis that administration of exogenous antioxidant alphatocopherol can restore a more balanced glucose homeostasis. The objective of the study was to evaluate the antihyperglycemic activity of Alphatocopherol in Streptozotocin induced diabetic rats. Albino rats of Sprague Dawley variety were divided into 3 groups of 30 each.Group-1 was the control group which was neither diabetic nor was provided with alphatocopherol, group-2 served as the diabetic control, which was made diabetic by an intraperitoneal injection of Streptozotocin but was fed with usual rodent feed while group-3 was the experimental group which was both diabetic and was also treated with alphatocopherol enriched diet. After 21 days of experimentation, blood sugar was estimated. Alphatocopherol produced a significant reduction in FBG in the STZ induced diabetic rats


Assuntos
Animais de Laboratório , Glicemia , Estreptozocina , Diabetes Mellitus Experimental , Hipoglicemiantes , Antioxidantes , Ratos Sprague-Dawley
2.
Medical Forum Monthly. 2008; 19 (12): 17-21
em Inglês | IMEMR | ID: emr-88719

RESUMO

Antioxidants are considered to be the effective and safe alternative and/or complementary treatments for diabetes mellitus. This study was aimed to assess the anti-dyslipidemic effects of alphatocopherol. We assess the hypothesis that administration of exogenous antioxidant alphatocopherol can restore a more balanced lipid homeostasis. The objective of the study was to evaluate the antidyslipidemic activity of Alphatocopherol in streptozotocin induced diabetic rats. Albino rats of Sprague Dawley variety were divided into 3 groups of 30 each. Group-1 was the control group which was neither diabetic nor was provided with alphatocopherol, group-2 served as the diabetic control, which was made diabetic by an intraperitoneal injection of streptozotocin but was fed with usual rodent feed while group-3 was the experimental group which was both diabetic and was also treated with alphatocopherol enriched diet. After 21 days of drug administration, blood lipid profile was estimated. Alphatocopherol produced a significant near normalization of the lipid profile


Assuntos
Masculino , Feminino , Animais de Laboratório , Dislipidemias/tratamento farmacológico , Diabetes Mellitus , Estreptozocina , Diabetes Mellitus Experimental , Antioxidantes , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA